Ribomic Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Public

  • Employees
  • 24

Employees

  • Stock Symbol
  • 4591

Stock Symbol

  • Share Price
  • $0.57
  • (As of Friday Closing)

Ribomic General Information

Description

Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.

Contact Information

Website
www.ribomic.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
TKS
Corporate Office
  • Shirokanedai Usui Building 6th Floor
  • 3-16-13 Shirokanedai
  • Tokyo, Minato-ku 108-0071
  • Japan
+81 00-0000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ribomic Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.57 $0.56 $0.51 - $1.13 $20.5M 36M 796K -$0.20

Ribomic Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022
EV (3,369) (3,369) 4,838 4,503
Revenue 0 0 487 720
EBITDA (7,010) (7,010) (12,208) (14,849)
Net Income (7,089) (7,089) (12,210) (14,996)
Total Assets 23,437 23,437 34,400 40,594
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ribomic Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ribomic‘s full profile, request access.

Request a free trial

Ribomic Patents

Ribomic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3187798-A1 Aptamer for il-21 and use thereof Pending 17-Jun-2020 000000000
EP-4170030-A1 Aptamer for il-21 and use thereof Pending 17-Jun-2020 000000000
AU-2021291555-A1 Aptamer for il-21 and use thereof Pending 17-Jun-2020 000000000
US-20230235333-A1 Aptamer for il-21 and use thereof Pending 17-Jun-2020 0000000000
US-20230065106-A1 Therapeutic agent for subretinal hyperreflective material or retinal disorders accompanying subretinal hyperreflective material Pending 06-Feb-2020 A61K31/7088
To view Ribomic’s complete patent history, request access »

Ribomic Executive Team (1)

Name Title Board Seat Contact Info
Yoshikazu Nakamura Ph.D Founder and President
To view Ribomic’s complete executive team members history, request access »

Ribomic Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ribomic Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ribomic‘s full profile, request access.

Request a free trial

Ribomic ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Ribomic’s complete esg history, request access »

Ribomic FAQs

  • When was Ribomic founded?

    Ribomic was founded in 2003.

  • Who is the founder of Ribomic?

    Yoshikazu Nakamura Ph.D is the founder of Ribomic.

  • Who is the CEO of Ribomic?

    Yoshikazu Nakamura Ph.D is the CEO of Ribomic.

  • Where is Ribomic headquartered?

    Ribomic is headquartered in Tokyo, Japan.

  • What is the size of Ribomic?

    Ribomic has 24 total employees.

  • What industry is Ribomic in?

    Ribomic’s primary industry is Drug Discovery.

  • Is Ribomic a private or public company?

    Ribomic is a Public company.

  • What is Ribomic’s stock symbol?

    The ticker symbol for Ribomic is 4591.

  • What is the current stock price of Ribomic?

    As of 12-Jul-2024 the stock price of Ribomic is $0.57.

  • What is the current market cap of Ribomic?

    The current market capitalization of Ribomic is $20.5M.

  • What is Ribomic’s annual earnings per share (EPS)?

    Ribomic’s EPS for 12 months was -$0.20.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »